Evaluation of a Non-cross-linked Porcine Acellular Dermal Matrix Used in Dental Surgery
NCT ID: NCT05435976
Last Updated: 2025-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
50 participants
OBSERVATIONAL
2022-09-12
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study will be a prospective multicentric non-randomized and noncontrolled trial involving 50 patients followed for 24 months. The study will be conducted in France in 4 investigational centres.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety Evaluation Study of Implants With Periodontal Ligament
NCT07302581
Performance and Safety Use of the Mono Block Implant "KONTACT MB"
NCT05016258
Prospective Study to Evaluate the Performance and Safety of Personalized Implants in Cranio-Maxillofacial (CMF) Surgery Indicated for Orthognathic Surgery
NCT05073757
Evaluation of the Safety and Performance of the TriOSS®: A Prospective Observational Study in Dental Area
NCT06813885
Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area
NCT07179510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All evaluations will be performed and products used according to the usual practice and the device IFU. CELLIS Dental will be used in accordance with its approved labelling.
The study will be conducted in France in 4 investigational centres including 50 patients scheduled for dental regeneration of soft tissue defects and development of soft tissues around teeth or implants.
Each patient will participate in one assessment period including a preoperative visit followed by the surgical procedure.
Patients will return for ambulatory visits on day 15 (+/- 5 days), on month 3 (+/- 2 weeks), on month 12 (+/- 2 weeks) and on month 24 (+/-2 weeks) post-surgery.
CELLIS Dental will be implanted following standard techniques according to indications:
* Treatment of recession defects (gingival recession),
* Soft tissue augmentation around teeth and implants,
* Soft tissue grafting in combination with GBR/GTR,
* Covering/sealing of extraction sockets.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CELLIS Dental (Porcine Acellular Dermal Matrix, PADM)
Biological membranes used in dental surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with an indication of keratinized soft tissue regeneration in the buccal cavity and/or keratinized soft tissue development around teeth or implants,
* Patient being informed of his participation to the study and of the follow-up visits, and having given his written informed consent,
* Patient being informed of the porcine origin of the device in advance of the procedure.
Exclusion Criteria
* Patient with acute or chronic infection or inflammation of the buccal cavity,
* Patient with a general illness contra-indicated for implantology, periodontology, stomatology, cranio-maxillo-facial surgery,
* Patient who is pregnant,
* Patient who is incapacitated including protected and deprived of liberty person,
* Patient having refused to participate in the study,
* Patient refusing to return for the follow-up visits.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meccellis Biotech
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rémy CAHUZAC
Role: PRINCIPAL_INVESTIGATOR
Cabinet dentaire des chênes, Saint Pierre du Mont, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet dentaire Grange Blanche
Lyon, , France
Cabinet PISB
Saint-Brieuc, , France
CMCT (Centre Médico-Chirurgical de Touraine)
Saint-Cyr-sur-Loire, , France
Cabinet dentaire des chênes
Saint-Pierre-du-Mont, , France
Cabinet dentaire Saint Priest en Jarez
Saint-Priest-en-Jarez, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DS_01_CIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.